Research map: Advancing Influenza Prevention: The Case for Pre-Exposure Prophylaxis (PrEP)

Back to the article

Papers in this map

  1. Influenza Pandemics of the 20th Century · Edwin D. Kilbourne · 2006 · 1249 citations · Cited by this paper
  2. Site-Specific Glycosylation Profiling of Protein Subunit and Inactivated Virus Vaccines · 2026 · Related
  3. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations · Virginia A. Fonner · 2016 · 1037 citations · Cited by this paper
  4. Protection and Duration of 23-Valent Pneumococcal Polysaccharide Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older Adults with Low Vaccination Coverage: A Multicenter Matched Case–Control Study in China · 2026 · Related
  5. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa · Timothy M. Uyeki · 2018 · 808 citations · Cited by this paper
  6. A GM-CSF-Flt3L Fused Adjuvant Enhances Immune Responses and Protective Efficacy of Influenza DNA Vaccine in Mice · 2026 · Related
  7. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies · Edward A. Belongia · 2016 · 729 citations · Cited by this paper
  8. Association Between Varicella Vaccination Status and Self-Reported Contact History Among Confirmed Varicella Cases in Chaoyang District, Beijing, 2017–2025 · 2026 · Related
  9. Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 · Myron J. Levin · 2022 · 678 citations · Cited by this paper
  10. Awareness and Knowledge Levels of Cervical Cancer and HPV and Attitudes Toward HPV Vaccination in Algeria · 2026 · Related
  11. Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts A Randomized Controlled Trial · Charles Welliver · 2001 · 468 citations · Cited by this paper
  12. Bidirectional Interplay Between Tumor Vaccines and the Tumor Microenvironment: Mechanisms, Cold-to-Hot Conversion, and Combination Strategies · 2026 · Related
  13. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa · Timothy M. Uyeki · 2019 · 426 citations · Cited by this paper
  14. Yellow Fever Vaccination in an Individual with Confirmed Egg Protein Allergy: A Case Report · 2026 · Related
  15. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials · Nicola J. Cooper · 2003 · 358 citations · Cited by this paper
  16. Untangling the Roots of HPV Vaccine Acceptance in West Virginia: How Hesitancy and Misinformation Shape Parental Decisions · 2026 · Related
  17. Zanamivir in the Prevention of Influenza Among Healthy Adults · Arnold S. Monto · 1999 · 326 citations · Cited by this paper
  18. A Multi-State, Cross-Sectional Retrospective Study on Knowledge, Attitude and Practice of Rabies Post-Exposure Prophylaxis Including Rabies Monoclonal Antibody Among Physicians Across India · 2026 · Related
  19. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons · Colleen Frances Kelley · 2024 · 287 citations · Cited by this paper
  20. Human Papillomavirus Vaccine Intent and Associated Factors Among the Unvaccinated University Freshmen in the Largest University Town in China · 2026 · Related
  21. Chasing Seasonal Influenza — The Need for a Universal Influenza Vaccine · Catharine I. Paules · 2017 · 270 citations · Cited by this paper
  22. Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts · Hideyuki Ikematsu · 2020 · 174 citations · Cited by this paper
  23. A systematic review of long‐term care facility characteristics associated with COVID ‐19 outcomes · Rita Tamara Konetzka · 2021 · 140 citations · Cited by this paper
  24. Efficacy and Tolerability of the Oral Neuraminidase Inhibitor Peramivir in Experimental Human Influenza: Randomized, Controlled Trials for Prophylaxis and Treatment · Luis F. Barroso · 2005 · 129 citations · Cited by this paper
  25. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA · Sandhya Bangaru · 2018 · 113 citations · Cited by this paper
  26. Influenza Vaccines: From Surveillance Through Production to Protection · Pritish K. Tosh · 2010 · 108 citations · Cited by this paper
  27. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial · Christopher Butler · 2019 · 107 citations · Cited by this paper
  28. Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data · Nicole E. Basta · 2008 · 91 citations · Cited by this paper
  29. Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza · Omar Ali · 2018 · 83 citations · Cited by this paper
  30. Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States · Manish M. Patel · 2020 · 81 citations · Cited by this paper
  31. Risk of Pneumococcal Disease in US Adults by Age and Risk Profile · Lindsay R. Grant · 2023 · 60 citations · Cited by this paper
  32. The Public Health Threat of Emerging Viral Disease · Stephen S. Morse · 1997 · 51 citations · Cited by this paper
  33. Characterization of COVID-19 in Assisted Living Facilities — 39 States, October 2020 · Sarah H. Yi · 2020 · 47 citations · Cited by this paper
  34. Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID ‐19 in immunocompromised patients · Rhea Suribhatla · 2023 · 41 citations · Cited by this paper
  35. SARS-CoV-2 Exposure and Infection Among Health Care Personnel — Minnesota, March 6–July 11, 2020 · Ashley Fell · 2020 · 37 citations · Cited by this paper
  36. Recommendations for Prevention and Control of Influenza in Children, 2024–2025: Policy Statement · Sean T. O’Leary · 2024 · 34 citations · Cited by this paper
  37. Factors influencing the immunogenicity of influenza vaccines · Simin Wen · 2021 · 32 citations · Cited by this paper
  38. A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration · Anna L. Beukenhorst · 2024 · 27 citations · Cited by this paper
  39. A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA) · Susanna K. Tan · 2024 · 22 citations · Cited by this paper

Source: OpenAlex (CC0)